Company Filing History:
Years Active: 2013-2015
Title: Brittney S Bates: Innovator in Neurological Research
Introduction
Brittney S Bates is a prominent inventor based in Nashville, TN (US). She has made significant contributions to the field of neuroscience, particularly in the development of compounds that target the metabotropic glutamate receptor subtype 5 (mGluR5). With a total of 5 patents to her name, her work is paving the way for new treatments for neurological and psychiatric disorders.
Latest Patents
Brittney's latest patents include innovative negative allosteric modulators of mGluR5. These patents detail synthetic methods for creating these compounds, as well as pharmaceutical compositions that incorporate them. The methods outlined in her patents aim to treat neurological and psychiatric disorders associated with glutamate dysfunction. The abstracts of her patents serve as valuable tools for searching within this specific area of research.
Career Highlights
Brittney S Bates is affiliated with Vanderbilt University, where she conducts her research. Her work has garnered attention for its potential impact on treating various neurological conditions. She is recognized for her dedication to advancing scientific knowledge and improving patient outcomes through her inventions.
Collaborations
Brittney collaborates with esteemed colleagues, including P Jeffrey Conn and Craig William Lindsley. These partnerships enhance the scope and depth of her research, contributing to the development of innovative solutions in the field of neuroscience.
Conclusion
Brittney S Bates is a trailblazer in the realm of neurological research, with a focus on developing novel treatments for disorders linked to glutamate dysfunction. Her contributions through her patents and collaborations are shaping the future of therapeutic interventions.